872976519	872976519	CD	B-NP	O
|	|	NN	I-NP	O
HAM	HAM	NN	I-NP	O
|	|	NN	I-NP	O
88133377	88133377	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
032338	032338	CD	B-NP	O
|	|	CC	I-NP	O
11/26/1997	11/26/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHRONIC	CHRONIC	NNP	I-NP	I-protein
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/1997	10/20/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/3/1997	2/3/1997	CD	B-NP	O
ADMITTING	ADMITTING	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ASTHMA/CHRONIC	ASTHMA/CHRONIC	NN	B-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
FLARE	FLARE	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ASTHMA/CHRONIC	ASTHMA/CHRONIC	NN	B-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
FLARE	FLARE	NN	I-NP	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
CORONARY	CORONARY	NNP	I-NP	O
ARTERY	ARTERY	NNP	I-NP	O
BYPASS	BYPASS	NNP	I-NP	O
GRAFT	GRAFT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
1994	1994	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

PAROXYSMAL	PAROXYSMAL	JJ	B-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

DEGENERATIVE	DEGENERATIVE	NNP	B-NP	O
JOINT	JOINT	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
BILATERAL	BILATERAL	NNP	I-NP	O
TOTAL	TOTAL	NNP	I-NP	O
KNEE	KNEE	NNP	I-NP	O
REPLACEMENT	REPLACEMENT	NNP	I-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
PARATHYROIDECTOMY	PARATHYROIDECTOMY	NNP	I-NP	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
.	.	.	O	O

BILATERAL	BILATERAL	JJ	B-NP	O
CATARACTS	CATARACTS	NNS	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75	75	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
nonproductive	nonproductive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
basically	basically	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
day	day	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
congestion	congestion	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
wheezing	wheezing	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
clear	clear	JJ	I-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
respirations	respiration	NNS	I-NP	O
were	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
angina	angina	NN	I-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Lomont	Lomont	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
where	where	WRB	B-ADVP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Daballginor	Daballginor	NNP	B-NP	O
Is	Is	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
at	at	IN	B-PP	O
WDUH	WDUH	NNP	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
deserved	deserve	VBD	B-VP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
very	very	RB	B-NP	O
mild	mild	JJ	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
bronchospastic	bronchospastic	JJ	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
and	and	CC	O	O
transferred	transfer	VBD	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
Albuterol	Albuterol	NNP	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NNP	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
glucose	glucose	NN	I-NP	O
intolerance	intolerance	NN	I-NP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
1.27	1.27	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
69	69	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-VP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
1.75	1.75	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NNP	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
1994	1994	CD	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
decreased	decrease	VBN	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
regional	regional	JJ	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
old	old	JJ	I-NP	O
apical	apical	JJ	I-NP	O
septal	septal	JJ	I-NP	O
and	and	CC	I-NP	O
inferobasilar	inferobasilar	JJ	I-NP	O
infarcts	infarct	NNS	I-NP	O
.	.	.	O	O

Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Biaxin	Biaxin	NN	B-NP	B-protein
and	and	CC	O	O
then	then	RB	B-VP	O
switched	switch	VBD	I-VP	O
to	to	TO	B-PP	O
Augmentin	Augmentin	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
issues	issue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Ri	Ri	NNP	B-NP	O
on	on	IN	B-PP	O
6	6	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
SVG	SVG	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
distal	distal	JJ	B-NP	O
OM1	OM1	NN	I-NP	O
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Insulin	Insulin	NN	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Paroxysmal	Paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Degenerative	Degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Asthma/chronic	Asthma/chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
parathyroidectomy	parathyroidectomy	NN	I-NP	O
for	for	IN	B-PP	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Chronic	Chronic	NNP	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
brown	brown	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
excision	excision	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
radius	radius	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Rectocele	Rectocele	NNP	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
1997	1997	CD	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cataracts	Cataract	NNPS	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
included	include	VBD	B-VP	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.5	.5	CD	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Premarin	Premarin	NN	B-NP	O
.625	.625	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	B-ADVP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
625	625	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
NPH	NPH	NN	I-NP	I-protein
12	12	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
3h	3h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Augmentin	Augmentin	IN	B-NP	O
250/125	250/125	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lotrimin	Lotrimin	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	I-NP	O
grown	grown	JJ	I-NP	O
children	child	NNS	I-NP	O
in	in	IN	B-PP	O
Harsaport	Harsaport	NNP	B-NP	O
The	The	NNP	I-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
ethanol	ethanol	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
female	female	NN	I-NP	O
sitting	sit	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
included	include	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
97.1	97.1	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
84	84	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
128/78	128/78	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
breathing	breathing	NN	B-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Moist	Moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
without	without	IN	B-PP	O
lesions	lesion	NNS	B-NP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotid	carotid	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
end	end	NN	I-NP	O
expiratory	expiratory	NN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
murmurs	murmur	NNS	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
scars	scar	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
with	with	IN	B-PP	O
tenderness	tenderness	NN	B-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphangitic	lymphangitic	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
137	137	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
49	49	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
129	129	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
was	be	VBD	B-VP	O
76	76	CD	B-NP	O
,	,	,	O	O
ferritin	ferritin	NN	B-NP	B-protein
236	236	CD	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
16.5	16.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
33.3	33.3	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
255	255	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MCV	MCV	NN	I-NP	O
of	of	IN	B-PP	O
89.7	89.7	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
demonstrated	demonstrate	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
left	left	JJ	I-NP	O
hemidiaphragm	hemidiaphragm	NN	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
vasculature	vasculature	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
notable	notable	JJ	B-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
70	70	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
old	old	JJ	B-NP	O
Q	Q	NNP	I-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
assessment	assessment	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
woman	woman	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease/bronchospastic	disease/bronchospastic	JJ	I-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
left	left	JJ	B-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
21	21	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
illness	illness	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Atrovent	Atrovent	NNP	B-NP	O
and	and	CC	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
slow	slow	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
peak	peak	NN	B-NP	O
flows	flow	NNS	I-NP	O
.	.	.	O	O

Peak	Peak	NN	B-NP	O
flow	flow	NN	I-NP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
around	around	RB	B-NP	O
200	200	CD	I-NP	O
and	and	CC	O	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Short	Short	NNP	I-NP	O
Stay	Stay	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
was	be	VBD	B-VP	O
about	about	IN	B-PP	O
250	250	CD	B-NP	O
.	.	.	O	O

Once	Once	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
noted	note	VBN	I-VP	O
significant	significant	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-NP	O
decreased	decrease	VBD	B-VP	O
02	02	CD	B-NP	O
,	,	,	O	O
essentially	essentially	RB	B-ADVP	O
to	to	TO	B-VP	O
require	require	VB	I-VP	O
no	no	DT	B-NP	O
02	02	CD	I-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
02	02	CD	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
metered	meter	VBN	B-NP	O
dose	dose	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
with	with	IN	B-PP	O
Aerochamber	Aerochamber	NNP	B-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
which	which	WDT	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
Serevent	Serevent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Vanceril	Vanceril	NNP	B-NP	O
four	four	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Albuterol	Albuterol	NN	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
noted	note	VBN	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Augmentin	Augmentin	NN	B-NP	O
for	for	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
bronchitis	bronchitis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
26	26	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
slight	slight	JJ	B-NP	O
scattered	scattered	JJ	I-NP	O
end	end	NN	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
moving	move	VBG	I-VP	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
discharge	discharge	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
on	on	IN	B-PP	O
Vanceril	Vanceril	NNP	B-NP	O
four	four	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Serevent	Serevent	NNP	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Albuterol	Albuterol	NN	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBN	B-VP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
p.r.n.	p.r.n.	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
peak	peak	JJ	I-NP	O
flow	flow	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
250	250	CD	I-NP	O
as	as	IN	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
notable	notable	JJ	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ledee	Ledee	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Left	Leave	VBN	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
bone	bone	NN	B-NP	O
films	film	NNS	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
Augmentin	Augmentin	NNP	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Bone	Bone	NN	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
ESR	ESR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
73	73	CD	B-NP	O
.	.	.	O	O

As	As	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
chronic	chronic	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
reading	reading	NN	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
diffusely	diffusely	RB	B-ADJP	O
hyperemic	hyperemic	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
potentially	potentially	RB	B-ADVP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
underperfused	underperfuse	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetic	diabetic	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
delayed	delay	VBN	I-NP	O
images	image	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
second	second	JJ	I-NP	O
proximal	proximal	JJ	I-NP	O
phalanx	phalanx	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
prominence	prominence	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
second	second	JJ	I-NP	O
metatarsophalangeal	metatarsophalangeal	JJ	I-NP	O
joint	joint	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
prominence	prominence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
right	right	JJ	I-NP	O
mid	mid	JJ	I-NP	O
foot	foot	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
metatarsophalangeal	metatarsophalangeal	JJ	I-NP	O
joints	joint	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
three	three	CD	I-NP	O
metatarsals	metatarsal	NNS	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
neuropathic	neuropathic	JJ	B-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
prominence	prominence	NN	I-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
prosthetic	prosthetic	JJ	B-NP	O
loosening	loosening	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
essence	essence	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
osteomyelitic	osteomyelitic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Augmentin	Augmentin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
worsen	worsen	VB	I-VP	O
or	or	CC	O	O
not	not	RB	B-VP	O
improve	improve	VB	I-VP	O
fully	fully	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
primary	primary	JJ	I-NP	O
medical	medical	JJ	I-NP	O
doctors	doctor	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Tomkus	Tomkus	NNP	I-NP	O
or	or	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Lesesne	Lesesne	NNP	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
potentially	potentially	RB	B-ADVP	O
setting	set	VBG	B-VP	O
her	her	PRP$	B-NP	O
up	up	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Miscellaneous	Miscellaneous	NNP	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
26	26	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
and	and	CC	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alls	Alls	NNP	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease/asthma	disease/asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
to	to	TO	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Liddicoat	Liddicoat	NNP	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
endocrinologic	endocrinologic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
will	will	MD	B-VP	O
check	check	VB	I-VP	O
glucose	glucose	NN	B-NP	O
measurements	measurement	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
in	in	RP	B-PRT	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Augmentin	Augmentin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
times	time	NNS	I-NP	O
11	11	CD	I-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
625	625	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Premarin	Premarin	NN	B-NP	O
.625	.625	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
Proventil	Proventil	IN	B-PP	O
MDI	MDI	NN	B-NP	B-protein
with	with	IN	B-PP	O
spacer	spacer	NN	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	CD	B-NP	O
times	time	NNS	I-NP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
then	then	RB	B-ADVP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
then	then	RB	B-ADVP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
then	then	RB	B-ADVP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
then	then	RB	B-NP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
12	12	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.p.m.	q.p.m.	RB	I-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
and	and	CC	O	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
q.lunch	q.lunch	NN	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.p.m.	q.p.m.	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Serevent	Serevent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Vanceril	Vanceril	NNP	B-NP	O
four	four	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Lotrimin	Lotrimin	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
Cream	Cream	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
salt	salt	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	B-protein
.	.	.	O	O

ACTIVITIES	ACTIVITIES	NNS	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
RICHARD	RICHARD	NNP	B-NP	O
NUCHOLS	NUCHOLS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VE20	VE20	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LUTHER	LUTHER	NNP	B-NP	O
L.	L.	NNP	I-NP	O
DRAGULA	DRAGULA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MF7	MF7	NNP	I-NP	O
LN274/8540	LN274/8540	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
12949	12949	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

O9QKFE64DJ	O9QKFE64DJ	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/10/97	1/10/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/25/97	3/25/97	CD	B-NP	O

